Sign In
Buy LIFE
$16.89
-0.375 (-2.17%)
At Close: Jun 03, 2026
Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates
06:11pm, Thursday, 13'th May 2021
Atyr Pharma (LIFE) delivered earnings and revenue surprises of -50.00% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Atyr Pharma (LIFE) to Report a Decline in Earnings: What to Look Out for
03:47pm, Tuesday, 04'th May 2021
Atyr Pharma (LIFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Steroids and Sarcoidosis
08:00am, Tuesday, 20'th Apr 2021
Panel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00pm PT Panel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00
Findings demonstrate tumor inhibitory effects of ATYR2810 when used as a monotherapy or in combination with chemotherapy in models of non-small cell lung cancer.
aTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay Shukla on Q4 2020 Results - Earnings Call Transcript
08:49pm, Tuesday, 23'rd Mar 2021
aTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay Shukla on Q4 2020 Results - Earnings Call Transcript
aTyr Pharma: Q4 Earnings Insights
04:46pm, Tuesday, 23'rd Mar 2021
Shares of aTyr Pharma (NASDAQ:LIFE) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 69.48% over the past year to ($0.47), which beat the
aTyr Pharma Announces Fourth Quarter and Full Year 2020 Results and Provides Corporate Update
04:05pm, Tuesday, 23'rd Mar 2021
Completed enrollment of ATYR1923 clinical trial in patients with pulmonary sarcoidosis. Data is expected in the third quarter.
Atyr Pharma (LIFE) Moves 26.3% Higher: Will This Strength Last?
03:02am, Wednesday, 17'th Mar 2021
Atyr Pharma (LIFE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LIFE Stock: Increased Price Target Gives aTyr Pharma Shares a Big Lift
02:21pm, Tuesday, 16'th Mar 2021
Atyr Pharma (LIFE) stock is taking off on Tuesday after getting a price target update from Roth Capital analyst Zegbeh Jallah. The post LIFE Stock: Increased Price Target Gives aTyr Pharma Shares a Bi
7 Stocks With Important Insider Trading Signals That Say Sell
01:55pm, Friday, 12'th Feb 2021
These seven names have shown important insider trading signals after their rallies, meaning some insiders are taking profits in these stocks. The post 7 Stocks With Important Insider Trading Signals T
aTyr Pharma Announces New tRNA Synthetase Discovery Programs
08:00am, Thursday, 11'th Feb 2021
Advancement of selected AARS and DARS fragments primarily targeting cancer
aTyr Pharma to Present at BIO CEO & Investor Digital Conference
08:00am, Tuesday, 09'th Feb 2021
SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological path
aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases
08:00am, Friday, 22'nd Jan 2021
Poster to be presented at the 2021 Society for Laboratory Automation and Screening Digital International Conference and Exhibition.
Study met primary safety endpoint in moderate to severe hospitalized COVID-19 patients.
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q3 2020 Results - Earnings Call Transcript
05:56am, Friday, 13'th Nov 2020
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q3 2020 Results - Earnings Call Transcript
